AstraZeneca says lung cancer drug trial shows no significant improvement
Detailed results from one of AstraZeneca's (AZN.L), opens new tab key lung cancer trials released… Read More
Detailed results from one of AstraZeneca's (AZN.L), opens new tab key lung cancer trials released… Read More
SINGAPORE: British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion… Read More
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due… Read More
AstraZeneca (AZN.L), opens new tab said on Friday its blockbuster cancer drug Imfinzi helped improve… Read More
AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals, for $2 billion… Read More
LONDON: British pharmaceuticals giant AstraZeneca on Thursday announced a return to third-quarter profit on increased… Read More
AstraZeneca said on Monday two of its existing therapies were recommended for treating patients with… Read More
ISLAMABAD: With the positivity rate of coronavirus currently hovering at 9.48 per cent, the federal… Read More
A safety panel of the European drug regulator on Friday recommended adding a rare spinal… Read More
AstraZeneca said on Thursday that preliminary data from a trial showed that its COVID-19 shot,… Read More
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant,… Read More
AstraZeneca said on Tuesday it is working with Oxford University to produce a vaccine for… Read More
A major British study into mixing COVID-19 vaccines has found that people had a better… Read More
AstraZeneca said on Friday it was examining the impact of a new coronavirus variant that… Read More
AstraZeneca on Thursday cemented its lead in bringing a preventative COVID-19 shot for the non-infected… Read More
British pharmaceutical giant AstraZeneca said Friday it has begun to sell its Covid vaccine at… Read More
The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a… Read More
AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in… Read More
AstraZeneca has requested emergency use authorisation from US regulators for its new treatment to prevent… Read More
AstraZeneca's COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to… Read More